COMMON VARIABLE IMMUNODEFICIENCY
Clinical trials for COMMON VARIABLE IMMUNODEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new COMMON VARIABLE IMMUNODEFICIENCY trials appear
Sign up with your email to follow new studies for COMMON VARIABLE IMMUNODEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common supplement fight scarring in rare immune disease lungs?
Disease control ENROLLING_BY_INVITATIONThis study is testing if a supplement called Fisetin can help treat lung scarring in people with Common Variable Immunodeficiency (CVID), a rare immune disorder. Researchers will compare Fisetin to a placebo in 20 participants to see if it improves lung function, reduces lung sca…
Matched conditions: COMMON VARIABLE IMMUNODEFICIENCY
Phase: PHASE2 • Sponsor: Avni Joshi • Aim: Disease control
Last updated Apr 04, 2026 00:05 UTC
-
New transplant trial aims to 'Reboot' faulty immune systems
Disease control OngoingThis study is testing whether a transplant of healthy blood-forming stem cells from a donor can safely give people with serious T-cell immune disorders a new, working immune system. The goal is to control these often life-threatening conditions by replacing the faulty immune cell…
Matched conditions: COMMON VARIABLE IMMUNODEFICIENCY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope: rebuilding broken immune systems with donor cells
Disease control OngoingThis study is testing a treatment to rebuild the immune system in people with severe inherited immune deficiencies. Patients receive stem cells from a donor, which are meant to grow into healthy new immune cells. The goal is to control the disease and reduce life-threatening infe…
Matched conditions: COMMON VARIABLE IMMUNODEFICIENCY
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC